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1
Abstract
Methods have been developed for Mendelian randomization that can obtain consis-
tent causal estimates while relaxing the instrumental variable assumptions. These
include multivariable Mendelian randomization, in which a genetic variant may be
associated with multiple risk factors so long as any association with the outcome is
via the measured risk factors (measured pleiotropy), and the MR-Egger (Mendelian
randomization-Egger) method, in which a genetic variant may be directly associated
with the outcome not via the risk factor of interest, so long as the direct effects of
the variants on the outcome are uncorrelated with their associations with the risk
factor (unmeasured pleiotropy). In this paper, we extend the MR-Egger method to
a multivariable setting to correct for both measured and unmeasured pleiotropy. We
show, through theoretical arguments and a simulation study, that the multivariable
MR-Egger method has advantages over its univariable counterpart in terms of plausi-
bility of the assumption needed for consistent causal estimation, and power to detect
a causal effect when this assumption is satisfied. The methods are compared in an
applied analysis to investigate the causal effect of high-density lipoprotein cholesterol
on coronary heart disease risk. The multivariable MR-Egger method will be useful to
analyse high-dimensional data in situations where the risk factors are highly related
and it is difficult to find genetic variants specifically associated with the risk factor
of interest (multivariable by design), and as a sensitivity analysis when the genetic
variants are known to have pleiotropic effects on measured risk factors.
Keywords: Mendelian randomization, invalid instruments, pleiotropy, MR-Egger,
multivariable.
2
1 Introduction
Mendelian randomization (MR) uses genetic variants as instrumental variables to es-
timate the causal effect of a risk factor on an outcome using observational data [1, 2].
Increases in the scale of genome-wide association studies have led to large numbers of
genetic variants that are associated with candidate risk factors being discovered [3]. If
the variants explain additional variability in the risk factor then using multiple vari-
ants in a MR analysis will increase power to detect a causal effect [4, 5]. A pleiotropic
genetic variant is associated with multiple risk factors; such a variant is not a valid
instrumental variable and its inclusion in a (univariable) MR analysis may result in
biased causal estimates and inappropriate inferences [6]. As more variants are used in
an MR analysis, the chance of including a pleiotropic variant increases.
For some sets of risk factors, including lipid fractions, several risk factors have
common genetic predictors. Although such genetic variants are pleiotropic, they can
be used to estimate causal effects in a multivariable MR framework [7]. In multi-
variable MR, the instrumental variable assumptions are extended to allow a genetic
variant to be associated with multiple risk factors, provided all associated risk factors
are included in the analysis. Alternatively, when genetic variants are suspected to
violate the instrumental variable assumptions through unknown pleiotropic pathways,
methods have been developed to estimate consistent causal effects under weaker as-
sumptions. These include the weighted median [8] and MR-Egger [9] methods. The
extension of MR-Egger to a multivariable setting has been implemented by Helgadot-
tir et al. [10] as part of a sensitivity analysis in their applied work investigating the
effect of lipid fractions on coronary heart disease (CHD) risk. However, there remains
several methodological issues relating to the implementation of the method, and the
assumptions required.
In this paper, we expand univariable MR-Egger to the multivariable setting. In
Section 2, we introduce the conventional and MR-Egger methods in both univariable
and multivariable contexts. We provide an example analysis using published data on
lipid fractions and CHD risk (Section 3), and compare results from the different MR
methods in a simulation study (Section 4). Finally (Section 5), we discuss the results
of the paper and the implications for applied practice. Software code for implementing
all of the methods used in this paper is provided in the Web Appendix.
3
2 Methods
Initially, we consider the causal effect of a risk factor X on an outcome Y using ge-
netic variants Gj (j = 1, . . . , J) that are assumed to be uncorrelated (not in linkage
disequilibrium). Then, we expand to consider multiple risk factors X1, X2, . . . , XK .
Increasingly, MR investigations are implemented using summarized data from con-
sortia to leverage their large sample sizes, thereby improving the precision of causal
estimates [11]. We therefore assume that summarized data are available on the asso-
ciations of each genetic variant with the risk factor (or with each risk factor for the
multivariable setting) and with the outcome: the beta-coefficients (βˆXj , βˆYj ) and their
standard errors (se(βˆXj ), se(βˆYj )) from univariable regression on each variant Gj in
turn. We additionally assume that the associations of genetic variants with the risk
factor and the outcome, and the causal effect of the risk factor on the outcome, are
linear and homogeneous across the population; these assumptions are discussed in de-
tail elsewhere [12]. To distinguish between the parameters from the different methods
considered, we use the following subscript notation: UI (‘univariable inverse variance
weighted (IVW)’); UE (‘univariable MR-Egger’); MI (multivariable IVW); and ME
(‘multivariable MR-Egger’).
2.1 Univariable Mendelian randomization
In a univariable MR analysis, each genetic variant must satisfy the following criteria
to be a valid instrumental variable (IV):
• IV1: the variant is associated with the risk factor X ,
• IV2: the variant is independent of all confounders U of the risk factor–outcome
association, and
• IV3: the variant is independent of the outcome Y conditional on the risk factor
X and confounders U [13].
These assumptions imply that the genetic variant should not have an effect on
the outcome except via the risk factor. Under linearity assumptions, the association
between the genetic variant and the outcome can be decomposed into an indirect effect
via the risk factor and a direct effect:
βY j = αj + θβXj (1)
where θ is the causal effect of the risk factor on the outcome. Genetic variant j is
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pleiotropic if αj 6= 0, and αj is the direct effect of the genetic variant on the outcome.
Figure 1 contains a direct effect αj via an independent pathway, which violates the
IV3 assumption.
[Figure 1 should appear about here.]
With a single genetic variant, G1 say, the causal estimate is βˆY1/βˆX1 [14]. This is a
consistent estimate of the causal effect θ when α1 = 0. With multiple genetic variants,
the inverse-variance weighted (IVW) estimate is the weighted average of these causal
estimates [15], using the inverse of their approximate variances se(βˆYj )
2/βˆ2Xj as weights:
θˆUI =
∑
j βˆYj βˆXj se(βˆYj )
−2
∑
j βˆ
2
Xj
se(βˆYj)
−2
(2)
This estimate can also be obtained from individual-level data using the two-stage least
squares method [16]. Alternatively, the causal effect of the risk factor on the outcome
can be estimated using a weighted linear regression of the genetic association estimates
[17], with the intercept set to zero:
βˆYj = θUI βˆXj + ǫUIj , weights = se(βˆYj )
−2 (3)
The above weighted regression model, where the residual standard error is set to one,
is equivalent to performing a fixed-effect meta-analysis of the variant-specific causal
estimates [18]. Under a multiplicative random-effects model, the residual standard
error can be greater than one, allowing for heterogeneity in the causal estimates. The
point estimate from the fixed- and random-effect models will be the same, but the
standard error of the causal effect from the multiplicative random-effects model will
be larger if there is heterogeneity between the causal estimates. Throughout this paper,
we apply a multiplicative random-effects model to all the analyses.
The MR-Egger estimate is obtained using the same regression model as equation 2,
but allowing the intercept to be estimated [9]:
βˆYj = θ0UE + θUEβˆXj + ǫUEj , weights = se(βˆYj )
−2 (4)
If the genetic variants are not pleiotropic, then the intercept term should tend to zero
as the sample size increases, and the MR-Egger estimate (θˆUE) and the IVW estimate
(θˆUI) are both consistent estimates of the causal effect. Additionally, if the genetic
variants are pleiotropic but the direct effects α (bold symbols represent vectors across
the j genetic variants) are independent of the associations of the variants with the risk
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factor βX (known as the InSIDE assumption – Instrument Strength Independent of
Direct Effect), then the MR-Egger estimate will be a consistent estimate of θ [9, 19].
Under the InSIDE assumption, the intercept term θˆ0UE can be interpreted as an es-
timate of the average direct effect of the genetic variants [8]. If the average direct effect
is zero (referred to as ‘balanced pleiotropy’), and the InSIDE assumption is satisfied,
the intercept term should tend to zero as the sample size increases, and the MR-Egger
estimate (θˆUE) and the IVW estimate (θˆUI) are both consistent estimates of the causal
effect. If the intercept term differs from zero, then either the InSIDE assumption
is violated or the average direct effect differs from zero (referred to as ‘directional
pleiotropy’); this is a test of the validity of the instrumental variable assumptions (the
MR-Egger intercept test).
2.2 Multivariable Mendelian randomization
In a multivariable MR analysis, each genetic variant must satisfy the following criteria:
• IV1(M): the variant is associated with at least one of the risk factors Xk,
• IV2(M): the variant is independent of all confounders U of each of the risk factor–
outcome associations, and
• IV3(M): the variant is independent of the outcome Y conditional on the risk
factors Xk and confounders U [7].
Now, the association of the genetic variants with the outcome can be decomposed
into indirect effects via each of the risk factors and a residual direct effect α′j . Assuming
there are 3 risk factors and all relationships are linear:
βYj = α
′
j + θ1βX1j + θ2βX2j + θ3βX3j (5)
where θk is the causal effect of the risk factor k on the outcome (Figure 2). We
assume that the risk factors do not have causal effects on each other; we later relax
this assumption and allow for causal effects between the risk factors.
[Figure 2 should appear about here.]
As in the univariable setting, causal estimates of the effect of each risk factor on the
outcome can be obtained from individual-level data using the two-stage least squares
method [7]. The same estimates can also be obtained using multivariable weighted
linear regression of the genetic association estimates, with the intercept set to zero
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(referred to as the multivariable IVW method) [20]:
βˆYj = θ1MI βˆX1j + θ2MI βˆX2j + θ3MI βˆX3j + ǫMIj , weights = se(βˆYj )
−2 (6)
We propose the natural extension to multivariable MR-Egger using the same re-
gression model, but allowing the intercept to be estimated:
βˆYj = θ0ME + θ1ME βˆX1j + θ2ME βˆX2j + θ3ME βˆX3j + ǫMEj , weights = se(βˆYj)
−2 (7)
2.3 Assumptions for multivariable MR-Egger
We assume that the causal effect of risk factor 1 (θ1) is of interest and provide the
assumptions necessary for the MR-Egger estimate of θ1 to be consistent. If all of the
causal effects are to be interpreted then these assumptions must apply for each risk
factor.
If the βX1 parameters are independent of the βXk parameters for all k = 2, 3, . . . , K,
then the InSIDE assumption for multivariable MR-Egger is satisfied if the direct effects
of the genetic variants α′ are independent of βX1. More formally, we require:
βX1 ⊥ α
′, if βX1 ⊥ βX2 , . . . ,βXK (8)
for the estimate of θ1 from multivariable MR-Egger to be consistent. If the InSIDE
assumption is satisfied, then the weighted covariance of βX1 and α
′ (covw(α
′,βX1))
will tend to zero as the number of genetic variants J tends to infinity. The estimate
of θ1 from multivariable MR-Egger when the βX1 parameters are independent of βXk
for all k = 2, 3, . . . , K is:
θˆ1ME =
covw(βˆY , βˆX1)
varw(βˆX1)
N→∞
−−−→
covw(βY ,βX1)
varw(βX1)
= θ1 +
covw(α
′,βX1)
varw(βX1)
(9)
which is equal to θ1 if the InSIDE assumption is satisfied, where covw and varw repre-
sent the weighted covariance and weighted variance using the inverse-variance weights
se(βˆY j)
−2:
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covw(α
′,βX1) =
∑
j(α
′
j − α¯
′
w)(βX1j − β¯X1w) se(βˆY j)
−2
∑
j se(βˆY j)
−2
varw(βX1) =
∑
j(βX1j − β¯X1w)
2 se(βˆY j)
−2
∑
j se(βˆY j)
−2
α¯′w =
∑
j α
′
j se(βˆY j)
−2
∑
j se(βˆY j)
−2
β¯X1w =
∑
j βX1j se(βˆY j)
−2
∑
j se(βˆY j)
−2
(10)
If the βX1 parameters are correlated with at least one of the sets of βXk parameters
(k = 2, 3, . . . , K), then the InSIDE assumption is required to hold for βX1 and for all
of the βXk parameters that are correlated with βX1 . More formally, we require:
βXk ⊥ α
′, for all βXkcorrelated with βX1(including βX1 itself) (11)
For example, if k = 2, and βX1 is correlated with βX2 , we require both of the weighted
covariances of α′ with βX1 and βX2 to be zero to produce a consistent estimate of θ1.
The estimate of θ1 from multivariable MR-Egger with two risk factors where βX1 and
βX2 are correlated is:
θˆ1ME =
covw(βˆY , βˆX1) varw(βˆX2)− covw(βˆY , βˆX2) covw(βˆX1 , βˆX2)
varw(βˆX1) varw(βˆX2)− covw(βˆX1 , βˆX2)
2
N→∞
−−−→
covw(βY ,βX1) varw(βX2)− covw(βY ,βX2) covw(βX1 ,βX2)
varw(βX1) varw(βX2)− covw(βX1 ,βX2)
2
= θ1 +
covw(α
′,βX1) varw(βX2)− covw(α
′,βX2) covw(βX1 ,βX2)
varw(βX1) varw(βX2)− covw(βX1 ,βX2)
2
(12)
which is equal to θ1 if the InSIDE assumption holds with respect to βX1 and βX2 . As
more risk factors with correlated sets of association parameters with βX1 are included
in the multivariable MR-Egger model, additional terms will be added to the bias term
in equation 12, and the InSIDE assumption must hold for these additional risk factors
to obtain a consistent estimate of θ1.
The variance of the multivariable MR-Egger estimate θˆ1ME will be heavily influ-
enced by the denominator in the bias term of equation 12. As βX1 and βX2 become
more highly correlated, the standard error of the causal estimate θˆ1ME will increase,
and in some circumstances the estimate from multivariable MR-Egger will be less
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precise than the estimate from uniavriable MR-Egger. The precision of the causal es-
timates from multivariable MR-Egger and univariable MR-Egger is discussed further
in the Web Appendix.
2.4 Advantages of multivariable MR-Egger and comparison
with univariable MR-Egger
The bias for the causal estimate from univariable MR-Egger θˆUE depends on the
weighted covariance between α and βX1 , where:
αj = α
′
j +
K∑
i=2
θiβXij (13)
The expression in equation 13 follows from the multivariable framework outlined in
equation 5, where the direct effect for univariable MR-Egger has been decomposed
into the residual direct effect α′j of multivariable MR-Egger and the indirect effects
via each risk factor. The residual direct effect α′j will be altered with each additional
risk factor included in the multivariable MR-Egger model. If these additional risk
factors are causally associated with the outcome (θk 6= 0), then α′j will consist of fewer
components. It seems likely that the InSIDE assumption would be easier to satisfy
for multivariable MR-Egger than its univariable counterpart as the direct effect for
univariable MR-Egger consists of unmeasured and measured pleiotropy.
If the βX1 parameters are independent of the βXk parameters for all k = 2, 3, . . . , K,
then the second term in equation 13 (the measured direct effect) does not contribute
to the value of covw(α,βX1). Under this scenario, bias for the univariable and multi-
variable MR-Egger estimates depends on the same covariance term covw(α
′,βX1). As
a consequence, the estimates of the causal effects from univariable MR-Egger θˆUE and
multivariable MR-Egger θˆ1ME will be asymptotically the same. In this case, multivari-
able MR-Egger may improve precision of the causal estimate, but will not affect the
asymptotic bias.
When the βX1 parameters are correlated with at least one of the sets of βXk
parameters for k = 2, 3, . . . , K, the second term in equation 13 now contributes to
the value of covw(α,βX1). The InSIDE assumption for univariable MR-Egger will
therefore be automatically violated as the weighted covariance between α and βX1 will
not equal zero, resulting in biased causal estimates of θ1. If the InSIDE assumption
holds for multivariable MR-Egger, and βXk are included in the analysis model, then
θˆ1ME will still be a consistent estimate of θ1. Hence, in this case, multivariable MR-
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Egger should result in reduced bias compared with univariable MR-Egger.
2.5 Orientation of the genetic variants
Genetic associations represent the average change in the risk factor or the outcome per
additional copy of the reference allele. There is no biological rationale why associations
should be expressed with respect to either the major (wildtype) or the minor (variant)
allele. In the univariable and multivariable IVW methods, the estimate is not affected
by the choice of orientation, as the intercept is fixed at zero. However, in the univariable
and multivariable MR-Egger methods, changing the orientation of the variant affects
the intercept term and the causal estimate as the orientation affects the definition of
the pleiotropy terms αj and α
′
j . Consequently, for each choice of orientation, there is
a different version of the InSIDE assumption.
To ensure that the MR-Egger analysis does not depend on the reported reference
alleles, Bowden et al. [9] suggested the genetic variants in univariable MR-Egger be
orientated so the direction of association with the risk factor is either positive for all
variants or negative for all variants. However, this may not be possible for multivariable
MR-Egger as the same reference allele must be used for associations with each risk
factor and with the outcome. We suggest that the variants should be orientated with
respect to their associations with the risk factor of primary interest, although we
would recommend a sensitivity analysis considering different orientations if multiple
risk factors are of interest. If the genetic variants are all valid instruments, then
directional pleiotropy should not be detected with respect to any orientation.
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3 Example: causal effect of HDL-C on CHD risk
The effects of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), and triglycerides on the risk of coronary heart disease (CHD)
have been investigated by numerous MR studies [21]. For HDL-C, univariable MR
suggested a causally protective role against CHD risk, whereas univariable MR-Egger
provided no evidence of a causal effect and the test for directional pleiotropy was
statistically significant at the 5% level [8]. A null causal effect for HDL-C was also
reported from a multivariable MR analysis that included LDL-C and triglycerides using
the multivariable IVW method [7], although a small but protective causal effect was
estimated in a further multivariable MR analysis using a wider range of 185 genetic
variants [22].
We investigate the causal effect of HDL-C on CHD risk further using the mul-
tivariable MR-Egger method. We consider the 185 genetic variants having known
association with at least one of HDL-C, LDL-C and triglycerides at GWAS signifi-
cance in 188,578 participants reported by the Global Lipids Genetics Consortium [23].
The point estimates for the associations between these genetic variants and lipids were
taken from Do et al. [24]. The CARDIoGRAMplusC4D consortium consisting of 60,801
cases and 123,504 controls was used to obtain the estimates of the association between
the variants and CHD risk [25]. The IVW and MR-Egger methods were applied to
the data under univariable and multivariable frameworks as described in Section 2.
For the univariable IVW and MR-Egger methods, the models were fitted using two
sets of variants: firstly using all 185 variants; and secondly using all variants associ-
ated with HDL-C at GWAS level of significance. The genetic variants were orientated
with respect to the risk increasing allele for HDL-C. These analyses differ from those
provided in [22] and [24] as they use summarized data from different versions of the
CARDIoGRAMplusC4D study; here we use associations from the 2015 data release
[25].
The univariable IVW method suggested a significant protective effect of HDL-C
for both sets of variants with a causal odds ratio of 0.88 (95% CI: 0.80, 0.97) for
all variants (Table 1). This estimate attenuated to the null in the univariable MR-
Egger method (0.98, 95% CI: 0.87, 1.11) with evidence of directional pleiotropy (p-
value=0.004). The causal odds ratios from multivariable IVW (0.96, 95% CI: 0.89,
1.05) and multivariable MR-Egger (1.04, 95% CI: 0.94, 1.14) had opposite directions
of association, with both analyses indicating that HDL-C is not causally associated
with CHD risk. The significant result for directional pleiotropy in the multivariable
MR-Egger method suggests that LDL-C and triglycerides do not fully explain the direct
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effects of the genetic variants on the outcome, suggesting that there is still residual
pleiotropy via other unmeasured risk factors.
[Table 1 should appear about here.]
3.1 Varying the orientation of the genetic variants
As a sensitivity analysis, the multivariable MR-Egger method was re-performed with
the genetic variants orientated with respect to the risk increasing alleles for LDL-C
and triglycerides.
The causal estimates for HDL-C, LDL-C, and triglycerides from multivariable MR-
Egger when the variants were orientated with respect to HDL-C, LDL-C or triglycerides
are presented in Table 2. Estimates of the MR-Egger intercept are also provided for
the three models. To allow for comparisons between the multivariable methods, the
causal estimates from multivariable IVW are included in Table 2. The causal estimates
in bold follow the recommendation outlined in Section 2.5 that the genetic variants
should be orientated with respect to the risk factor-increasing allele for the risk factor
of interest.
All of the causal odds ratios for HDL-C from the multivariable MR-Egger models
indicated that HDL-C is not causally associated with CHD risk. Significant adverse ef-
fects of LDL-C on CHD risk were reported from the multivariable IVW (1.45, 95% CI:
1.34, 1.58) and multivariable MR-Egger (1.52, 95% CI: 1.37, 1.69) methods. Orientat-
ing the variants with respect to the risk increasing alleles for HDL-C and triglycerides
had little impact on the causal estimates for LDL-C from multivariable MR-Egger.
The multivariable IVW method suggested a significant adverse effect of triglycerides
on CHD risk with a causal odds ratio of 1.19 (95% CI: 1.07, 1.33), this estimate was
attenuated to the null in the multivariable MR-Egger method (1.09, 95% CI: 0.96,
1.23). The causal odds ratios for triglycerides remained significant, however, when
the variants were orientated with respect to HDL-C and LDL-C in the multivariable
MR-Egger models.
Since the orientation of the genetic variants affects the interpretation of the direct
effect, and the definition of the InSIDE assumption, the MR-Egger intercept will vary
between different orientations. In this example, the MR-Egger intercept differed from
zero when the variants were orientated with respect to HDL-C and triglycerides, yet
there was no evidence of directional pleiotropy or the InSIDE assumption being violated
when the variants were orientated with respect to LDL-C.
[Table 2 should appear about here.]
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4 Simulation study
In order to assess the merits of using multivariable MR-Egger over multivariable IVW
and univariable MR-Egger in realistic settings, we perform a simulation study. Uni-
variable and multivariable MR-Egger will be compared with respect to the consistency
of the causal estimates and statistical power to detect the causal effect. The setup
of the simulation study corresponds to the applied example in Section 3 and will be
considered under two broad scenarios: (1) βXk are generated independently for all
k = 1, 2, . . . , K; and (2) βXk are correlated for all k = 1, 2, . . . , K. Estimates of the
R2 and F-statistic for the applied example are provided in the Web Appendix.
We simulated summarized level data for 185 genetic variants indexed by j =
1, 2, . . . , J for three risk factors (X1, X2, X3) and an outcome Y from the following
data-generating model:


βX1j
βX2j
βX3j

 ∼ N3




0.08
0.03
−0.05

 ,


σ1
2 ρ12σ1σ2 ρ13σ1σ3
ρ12σ1σ2 σ2
2 ρ23σ2σ3
ρ13σ1σ3 ρ23σ2σ3 σ3
2




βY j = α
′
j + θ1|βX1j |+ θ2βX2j + θ3βX3j + ǫj
ǫj ∼ N (0, 1)
α′j ∼ N (µ, 0.004) (14)
The primary objective was to estimate θ1, with the causal effects set to: θ1 = 0 (null
causal effect) or θ1 = 0.3 (positive causal effect); θ2 = 0.1; and θ3 = −0.3. The data
were simulated to consider the following four scenarios:
1. No pleiotropy (α′j = 0 for all j), InSIDE assumption automatically satisfied;
2. Balanced pleiotropy (µ = 0), InSIDE assumption satisfied;
3. Directional pleiotropy (µ = 0.01, 0.05 or 0.1), InSIDE assumption satisfied;
4. Directional pleiotropy (µ = 0.01, 0.05 or 0.1), InSIDE assumption violated.
When the InSIDE assumption for multivariable MR-Egger was satisfied, α′j and βX1j
were drawn from independent distributions, and when it was violated they were drawn
from a multivariate normal distribution with cor(α′,βX1) = 0.3. The above four
scenarios were applied to the simulated data when βXk were generated independently
for all k, with the parameters in the covariance matrix set to: σ2
1
= 0.03; σ2
2
= 0.02;
σ2
3
= 0.04; and ρ12 = ρ13 = ρ23 = 0. The four scenarios were repeated when βXk were
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correlated for all k (ρ12 = 0.2, ρ13 = −0.3, ρ23 = 0.1). In total, data were simulated
for 32 different choices of parameters.
To ensure the direction of association between Gj and X1 was the same for all
j variants, the absolute value of the genetic associations with X1 (|βX1j |) were used
to generate βYj (equation 14). It was assumed that βXkj (for all k) and βYj had the
same reference allele and the genetic variants were uncorrelated. The multivariable
IVW, univariable MR-Egger and multivariable MR-Egger methods were applied to
the simulated datasets. The weights for the multivariable IVW and multivariable MR-
Egger are given by equation 15, while equation 16 contains the weights for univariable
MR-Egger.
se(βYj )
−2 = (ǫj
2 + σα′
2)
−1
(15)
se(βYj )
−2 = (ǫj
2 + σα′
2 + θ2
2σ2
2 + θ3
2σ3
2)
−1
(16)
4.1 Results
The results from the simulation study using 10 000 simulated datasets are presented
in Table 3 (βXk generated independently) and Table 4 (βXk correlated). For each
scenario, the mean estimate, the mean standard error, and the statistical power to
detect a null or positive causal effect at a nominal 5% significance level are presented
in Tables 3 and 4 for the multivariable IVW, univariable MR-Egger and multivariable
MR-Egger methods. For univariable and multivariable MR-Egger, the statistical power
of the MR-Egger intercept test is also provided.
βXk generated independently: In scenarios 1 and 2 (no and balanced pleiotropy),
estimates from all methods were unbiased, and those from the multivariable IVW
method were the most precise. In scenarios 3 and 4 (directional pleiotropy), estimates
from the multivariable IVW method were biased, with the magnitude of bias increasing
as the average value of α′ increased from 0.01 to 0.1. In scenario 3 (InSIDE satisfied),
estimates from the univariable and multivariable MR-Egger methods were unbiased,
whereas in scenario 4 (InSIDE violated), they were biased. Although the causal es-
timates for both multivariable IVW and multivariable MR-Egger were biased under
scenario 4, the magnitude of bias was less for multivariable MR-Egger, with the ex-
ception of when α′j was generated from N (0.01, 0.004). Precision and power to detect
a causal effect were always better for the multivariable MR-Egger method than uni-
variable MR-Egger, although the univariable MR-Egger method detected directional
pleiotropy more often. The average value of α′ had no impact on the degree of bias
for univariable or multivariable MR-Egger.
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βXk correlated: Bias for the multivariable IVW method was present in scenarios
3 and 4 only, as in the independently generated setting. In this setting, the InSIDE
assumption for univariable MR-Egger was violated for all four scenarios, resulting
in biased point estimates of θ1. However, the multivariable InSIDE assumption was
satisfied for scenarios 1, 2 and 3, and so causal estimates from multivariable MR-Egger
were unbiased. When the multivariable InSIDE assumption was violated (scenario 4)
the estimates from multivariable MR-Egger were biased, yet the magnitude of bias was
less compared with univariable MR-Egger as | cov(α′,βX1)| < | cov(α,βX1)|.
[Table 3 should appear about here.]
[Table 4 should appear about here.]
4.2 Causal relationships between the risk factors
The simulations performed in Section 4.1 assumed that the effect of each risk factor on
the outcome is not mediated through another risk factor. There may be circumstances
where causal relationships between risk factors are biologically plausible. Burgess et al.
[7] illustrated that the multivariable IVW method estimates the direct causal effects
(θk) of each risk factor on the outcome, irrespective of whether causal relationships
between the risk factors exist.
In the applied example of the paper, there may also be deterministic dependen-
cies between the risk factors. LDL-C is rarely measured directly, but is estimated
from measurements of total cholesterol, triglycerides and HDL-C via the Friedewald
equation as total cholesterol minus HDL-C minus 0.2 times triglycerides (assuming all
measurements in mg/dL) [26]. It has previously been shown that the coefficient for
LDL-C is the same as the coefficient for non-HDL-C (calculated as total cholesterol
minus HDL-C) in a regression model including HDL-C and triglycerides (see Appendix
2 in [27]). However, the coefficient for triglycerides will change, as the non-HDL-c mea-
sure contains more triglycerides than the LDL-c measure. Hence, in the case that there
are deterministic relationships between the risk factors, effect estimates may change as
the choice of risk factors varies due to their interpretation as direct effects conditional
on other risk factors in the regression model.
We performed additional simualtions to investigate the behaviour of the multivari-
able MR-Egger method when X2 is causally dependent on X1, and the causal effect of
X1 on X2 is γ (Figure 3). The total causal effect of X1 on Y is θ1 + γθ2; consisting of
the direct effect (θ1) and the indirect effect via X2 (γθ2). See the Web Appendix for
more details on the data generating model.
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[Figure 3 should appear about here.]
4.2.1 Results
The results from the additional simulations are provided in Web Table A1 and Web
Table A2. In scenarios where there was no bias in the original set of simulations, the
multivariable IVW and multivariable MR-Egger methods consistently estimated the
direct effect of X1 on Y (θ1), whilst the univariable MR-Egger method consistently
estimated the total causal effect of X1 on Y (θ1 + γθ2). Compared to the results
in Section 4.1, precision and power to detect a causal effect were reduced for the
multivariable IVW and multivariable MR-Egger methods. This reduction in power was
anticipated since the multivariable models condition on the mediator along a causal
pathway, which is known to decrease power to detect a causal effect [28].
16
5 Discussion
In this paper we have extended univariable MR-Egger to the multivariable setting and
outlined the assumptions required to obtain consistent causal estimates in the presence
of directional pleiotropy. Multivariable MR-Egger should be viewed as a sensitivity
analysis to provide robustness against both measured and unmeasured pleiotropy, and
to strengthen the evidence from the original MR analysis. If the causal estimate from
multivariable MR-Egger is substantially different from the estimate obtained in the
original analysis, then further investigation into the causal finding and the potential
for pleiotropy is required.
The simulation study has highlighted the benefits of using multivariable MR-Egger
over its univariable counterpart. This is particularly true when the associations of the
genetic variants with the risk factor of interest are associated with genetic associations
with at least one of the risk factors (measured pleiotropy). Under this scenario, the
InSIDE assumption for univariable MR-Egger is likely to be violated, leading to biased
causal estimates. Multivariable MR-Egger will, however, produce consistent causal
estimates if the InSIDE assumption for multivariable MR-Egger is satisfied. Although
the estimates from univariable and multivariable MR-Egger are asymptotically the
same when genetic associations with each risk factor are all independent, multivariable
MR-Egger should also have greater power to detect a causal effect when the InSIDE
assumption is satisfied. Given these advantages, and the sensitivity of the multivariable
IVW method to directional pleiotropy, we believe that multivariable MR-Egger should
be considered as an important sensitivity analysis for a MR study.
5.1 Multivariable by design, or multivariable as a sensitivity
analysis?
There are two possible scenarios where multivariable MR-Egger may be used as a sensi-
tivity analysis: either the primary analysis is considered to be multivariable by design,
or a multivariable framework is only considered as part of the sensitivity analysis. The
first case should be motivated by biological evidence where the set of risk factors are
known to be associated with common genetic variants, such as lipid fractions. Un-
der this scenario, multivariable IVW should be used as the primary analysis method
with multivariable MR-Egger providing robustness against directional pleiotropy as a
sensitivity analysis.
In the second scenario, where there is a lack of biological evidence to suggest a mul-
tivariable framework, univariable IVW would generally be considered as the primary
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analysis method and univariable MR-Egger as the main sensitivity analysis. However,
if the genetic variants are associated with other risk factors, multivariable MR-Egger
could also be used as a sensitivity analysis as its assumptions are more likely to be
satisfied and it may have greater power to detect a causal effect than univariable MR-
Egger. An example of the use of multivariable MR as a sensitivity analysis is an MR
study on plasma urate concentrations and CHD risk [29]. To account for measured and
unmeasured pleiotropic associations of the genetic variants, the authors performed the
multivariable IVW and univariable MR-Egger methods as sensitivity analyses. This
investigation may have benefited from performing the multivariable MR-Egger method
to simultaneously account for both measured and unmeasured pleiotropic associations.
5.2 InSIDE assumption and orientation of genetic variants
The validity of multivariable MR-Egger and its ability to estimate consistent causal
effects is dependent upon the InSIDE assumption being satisfied. Whilst it is not
possible to determine whether the InSIDE assumption has been violated, we believe it
is more likely to hold for multivariable MR-Egger then univariable MR-Egger. When
the βX1 parameters are associated with at least one of the sets of βXk parameters
for k = 2, 3, . . . , K, the InSIDE assumption for univariable MR-Egger is automatically
violated and causal estimates from the method will be inconsistent. The direct effects of
the genetic variants on the outcome will consist of fewer components for multivariable
MR-Egger compared to its univariable counterpart, making it more plausible that the
InSIDE assumption will hold for multivariable MR-Egger.
The recommendation of orientating the genetic variants in multivariable MR-Egger
to the risk factor-increasing or risk factor-decreasing allele for the risk factor of interest
may be considered arbitrary. While we accept this limitation, we would argue it
brings consistency to the results. This recommendation may result in the analysis
being performed up to K times to obtain the causal estimates for all K risk factors.
The orientation of the genetic variants will also affect the interpretation of the direct
effect, thereby altering the InSIDE assumption. This may result in the MR-Egger
intercept estimate varying between different orientations. This was seen in the applied
example where the intercept term was non-significant when the alleles were orientated
with respect to LDL-C, and significant when orientated with respect to HDL-C and
trigclyercides.
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5.3 Linearity and homogeneity assumptions
Throughout this paper we have assumed linearity and homogeneity (no effect modifi-
cation) of the causal effects of the risk factors on the outcome, and of the associations
between the genetic variants with the risk factors and with the outcome. If the as-
sumptions of linearity and homogeneity are violated then the methods discussed in
this paper still provide a valid test for the null hypothesis of whether the risk factor
is causally associated with the outcome [12]. The causal estimate, however, would not
have a literal interpretation if the assumptions were violated [30]. Although linearity
and homogeneity are strong assumptions, the effect of genetic variants on the risk fac-
tor and outcome tend to be limited to a small range, which may make the assumptions
of linearity and homogeneity more reasonable in an MR analysis.
The multivariable models have assumed that the risk factors do not have causal
effects on each other. The additional simulation study has illustrated that the mul-
tivariable MR-Egger method estimates the direct causal effects of the risk factors on
the outcome, irrespective of whether the risk factors are causally related. There was,
however, a reduction in precision and power to detect the causal effect for multivariable
MR-Egger when a causal relationship between the risk factors was present. Conversely,
univariable MR-Egger will produce consistent causal estimates of the total effect if the
InSIDE assumption for univariable MR-Egger is satisfied.
5.4 Implication for future research
The paper by Helgadottir et al. [10] highlights the importance and need to develop
sensitivity analyses for multivariable MR. This is particularly relevant given the recent
advances in high-throughput phenotyping which has led to the introduction of ‘-omics’
data such as metabolomics, genomics, and proteomics [31]. Genome-wide analyses
of high-dimensional ‘-omics’ data are becoming more popular [32, 33], yet few MR
analyses have been performed using these datasets [21]. As summarized data from large
consortia become more accessible, the opportunities to use MR on high-dimensional
datasets will only increase. Methods such as multivariable MR-Egger will be valuable
to investigate the causal effects of multiple related phenotypes with shared genetic
predictors.
Bowden et al [34] have shown that uncertainty in the associations between the
genetic variants and the risk factor in univariable MR-Egger can lead to attenuation
towards the null for a positive causal effect. This attenuation is approximately equal
to the I2 statistic from meta-analysis of the weighted associations with the exposure
βˆXj se(βˆY j)
−1 with standard errors se(βˆXj) se(βˆY j)
−1 [34]. It is unclear whether the
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method proposed by Bowden et al [34] can be directly applied to the multivariable
setting. The effect of regression dilution bias in a multivariable regression model can
lead to the association being over-estimated, under-estimated or the direction of asso-
ciation being reversed [35]. However, in the simulation study considered in this paper,
substantial bias due to uncertainty in the genetic associations with the risk factor was
not observed. Further research is required to investigate this issue.
Throughout the paper, we have assumed that the genetic variants are uncorrelated
(not in linkage disequilibrium). This assumption, and the requirement for further
methodological development, is discussed in the Web Appendix.
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Tables
Table 1: Log causal odds ratios (95% confidence intervals) for coronary heart disease per standard de-
viation increase in HDL-C, with two-sided p-values. Estimates of the intercept are given in univariable
and multivariable MR-Egger.
Causal estimate MR-Egger intercept test
θˆHDL-C (CI) se(θˆHDL-C) p-value θˆ0E se(θˆ0E) p-value
Univariable IVW
All variants -0.130 (-0.227, -0.033) 0.049 0.009 - - -
Reduced set of variantsa -0.114 (-0.211, -0.017) 0.049 0.022 - - -
Univariable MR-Egger
All variants -0.016 (-0.138, 0.106) 0.062 0.800 -0.007 0.002 0.004
Reduced set of variantsa 0.067 (-0.070, 0.204) 0.069 0.332 -0.012 0.004 0.001
Multivariable IVW -0.039 (-0.123, 0.045) 0.042 0.359 - - -
Multivariable MR-Egger 0.036 (-0.063, 0.134) 0.050 0.477 -0.005 0.002 0.008
Abbreviations: MR, Mendelian randomization; HDL-C, high-density lipoprotein cholesterol; IVW,
inverse-variance weighted; CI, confidence interval; SE, standard error.
a95 variants associated with HDL-C at a genome-wide level of significance (p-value< 5× 10−8).
Table 2: Causal log odds ratios (95% confidence intervals) for coronary heart disease per standard
deviation increase in HDL-C, LDL-C, and triglycerides frommultivariable IVW and multivariable MR-
Egger. Estimates from multivariable MR-Egger are presented from three models where the reference
allele is the risk increasing allele for HDL-C, LDL-C or triglycerides. Estimates of the intercept are
given for multivariable MR-Egger.
Causal estimates MR-Egger intercept
θˆHDL-C θˆLDL-C θˆTG θˆ0E
Multivariable IVW -0.039 (-0.123, 0.045) 0.375 (0.292, 0.457) 0.173 (0.063, 0.283) -
Multivariable MR-Egger
Orientation with respect toa:
HDL-C 0.036 (-0.063, 0.134) 0.378 (0.297, 0.458) 0.136 (0.024, 0.247) -0.005 (-0.009, -0.001)
LDL-C -0.034 (-0.118, 0.049) 0.420 (0.318, 0.522) 0.194 (0.081, 0.308) -0.003 (-0.007, 0.001)
TG -0.018 (-0.102, 0.066) 0.350 (0.267, 0.433) 0.083 (-0.045, 0.211) 0.005 (0.001, 0.009)
Abbreviations: MR, Mendelian randomization; HDL-C, high-density lipoprotein cholesterol; LDL-C,
low-density lipoprotein cholesterol; TG, triglycerides.
aAlleles orientated for all genetic associations with respect to the risk increasing allele for HDL-C,
LDL-C or triglycerides.
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Table 3: Performance of multivariable IVW, univariable MR-Egger and multivariable MR-Egger with
respect to θˆ1 for a null (θ1 = 0) and positive (θ1 = 0.3) causal effect where βXk are generated
independently for all k. All tests were performed at the 5% level of significance.
Multivariable IVW Univariable MR-Egger Multivariable MR-Egger
Mean θˆ1 Power, Mean θˆ1 Power, % Mean θˆ1 Power, %
(mean SE) % (mean SE) Intercept Causal (mean SE) Intercept Causal
Null causal effect: θ1 = 0
1. No pleiotropy, InSIDE satisfied
0.000 (0.045) 3.8 -0.002 (0.158) 9.1 4.7 0.000 (0.084) 3.7 4.1
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) -0.001 (0.100) 4.7 -0.001 (0.187) 7.8 4.7 0.000 (0.165) 4.6 4.6
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.041 (0.100) 6.7 -0.003 (0.187) 12.2 4.3 -0.002 (0.165) 5.9 4.5
α′j ∼ N (0.05,0.004) 0.210 (0.100) 55.3 0.002 (0.187) 49.2 4.6 0.002 (0.166) 36.3 4.6
α′j ∼ N (0.1,0.004) 0.417 (0.102) 97.4 0.000 (0.187) 91.6 4.3 0.001 (0.165) 88.0 4.6
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.074 (0.100) 12.3 0.089 (0.187) 6.7 7.6 0.088 (0.165) 4.3 8.4
α′j ∼ N (0.05,0.004) 0.240 (0.100) 67.2 0.089 (0.187) 34.1 7.8 0.088 (0.165) 21.1 8.8
α′j ∼ N (0.1,0.004) 0.450 (0.101) 98.6 0.088 (0.187) 84.1 7.6 0.088 (0.165) 78.7 8.7
Positive causal effect: θ1 = 0.3
1. No pleiotropy, InSIDE satisfied
0.300 (0.044) 98.9 0.300 (0.157) 9.3 50.1 0.300 (0.084) 4.3 87.3
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) 0.301 (0.100) 84.6 0.303 (0.187) 7.5 38.2 0.302 (0.166) 4.9 46.4
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.343 (0.100) 91.5 0.300 (0.187) 12.8 36.8 0.299 (0.165) 6.0 45.8
α′j ∼ N (0.05,0.004) 0.509 (0.100) 99.7 0.300 (0.188) 50.6 37.3 0.299 (0.166) 37.1 46.1
α′j ∼ N (0.1,0.004) 0.716 (0.102) 100.0 0.300 (0.187) 91.1 37.1 0.299 (0.166) 87.9 46.1
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.374 (0.099) 94.3 0.390 (0.187) 6.6 56.4 0.389 (0.165) 4.6 65.8
α′j ∼ N (0.05,0.004) 0.539 (0.100) 99.8 0.388 (0.187) 34.4 55.6 0.387 (0.165) 21.5 65.5
α′j ∼ N (0.1,0.004) 0.747 (0.101) 100.0 0.383 (0.187) 84.7 55.1 0.384 (0.165) 78.3 65.2
Abbreviations: MR, Mendelian randomization; SE, standard error; IVW, inverse-variance weighted;
InSIDE, Instrument Strength Independent of Direct Effect.
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Table 4: Performance of multivariable IVW, univariable MR-Egger and multivariable MR-Egger with
βXk being correlated for all k.
Multivariable IVW Univariable MR-Egger Multivariable MR-Egger
Mean θˆ1 Power, Mean θˆ1 Power, % Mean θˆ1 Power, %
(mean SE) % (mean SE) Intercept Causal (mean SE) Intercept Causal
Null causal effect: θ1 = 0
1. No pleiotropy, InSIDE satisfied
0.000 (0.047) 4.0 0.099 (0.157) 4.3 10.1 0.000 (0.086) 4.4 4.6
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) -0.001 (0.104) 4.7 0.093 (0.187) 4.5 7.4 -0.003 (0.169) 4.6 4.4
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.043 (0.104) 7.0 0.099 (0.187) 5.8 8.0 0.001 (0.169) 5.9 4.8
α′j ∼ N (0.05,0.004) 0.213 (0.105) 52.7 0.095 (0.187) 33.3 7.6 0.000 (0.169) 37.2 4.5
α′j ∼ N (0.1,0.004) 0.426 (0.107) 96.3 0.096 (0.187) 84.5 7.6 -0.001 (0.169) 89.2 4.6
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.062 (0.104) 9.5 0.184 (0.187) 4.6 17.9 0.078 (0.169) 4.7 7.6
α′j ∼ N (0.05,0.004) 0.235 (0.104) 62.1 0.187 (0.187) 20.5 18.3 0.082 (0.169) 22.3 7.5
α′j ∼ N (0.1,0.004) 0.448 (0.106) 97.9 0.181 (0.187) 73.3 17.8 0.077 (0.169) 80.3 7.2
Positive causal effect: θ1 = 0.3
1. No pleiotropy, InSIDE satisfied
0.300 (0.047) 98.7 0.395 (0.158) 4.4 70.8 0.299 (0.087) 3.9 86.2
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) 0.300 (0.104) 81.5 0.399 (0.187) 4.4 58.0 0.301 (0.169) 4.6 44.4
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.342 (0.104) 89.4 0.395 (0.187) 6.4 57.4 0.301 (0.169) 5.9 44.4
α′j ∼ N (0.05,0.004) 0.513 (0.105) 99.4 0.394 (0.187) 33.0 57.4 0.296 (0.169) 38.0 43.4
α′j ∼ N (0.1,0.004) 0.729 (0.107) 100.0 0.400 (0.187) 83.5 58.2 0.304 (0.169) 88.6 45.5
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.365 (0.104) 92.1 0.489 (0.187) 4.2 74.0 0.382 (0.169) 4.6 63.2
α′j ∼ N (0.05,0.004) 0.535 (0.104) 99.7 0.486 (0.187) 20.3 72.9 0.382 (0.169) 21.1 63.2
α′j ∼ N (0.1,0.004) 0.749 (0.106) 100.0 0.488 (0.187) 72.5 73.4 0.381 (0.169) 79.6 62.8
Abbreviations: MR, Mendelian randomization; SE, standard error; IVW, inverse-variance weighted;
InSIDE, Instrument Strength Independent of Direct Effect.
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Figure 1: Causal directed acyclic graph illustrating univariable Mendelian randomization assumptions
with potential violation of IV3 by a pleiotropic effect indicated by a dotted line. The genetic effect
of Gj on X is βXj , the direct (pleiotropic) effect of Gj on Y via an independent pathway is αj
(representing the potential violation of the IV3 assumption), and the causal effect of the risk factor
X on the outcome Y is θ. U represents the set of variables that confound the association between X
and Y .
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Figure 2: Causal directed acyclic graph illustrating multivariable Mendelian randomization assump-
tions for a set of genetic variants Gj , three risk factors X1, X2 and X3, and outcome Y. The genetic
effect of Gj on Xk is βXkj , the direct (pleiotropic) effect of Gj on Y is α
′
j , and the causal effect
of the risk factor Xk on the outcome Y is θk. Uk represents the set of variables that confound the
associations between Xk and Y .
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Figure 3: Causal directed acyclic graph illustrating the causal relationships between the two risk
factors X1 and X2, and outcome Y . The causal effect of X1 on X2 is γ, and the direct causal effect of
the risk factor Xk on the outcome Y is θk. The total causal effect of X1 on Y is θ1 + γθ2; consisting
of the direct effect (θ1) and the indirect effect via X2 (γθ2). Uk represents the set of variables that
confound the associations between Xk and Y .
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Web Appendix
A1 Sample software code
We provide sample code written in R to perform the analyses described in this pa-
per. The associations of the genetic variants with the risk factors are denoted bXk
with standard error bXk se, where k = 1, ..., K. The associations of the genetic
variants with the outcome are denoted bY with standard error bYse. The code for
the multivariable models will be based on three risk factors and can be easily adapted
to include the appropriate number of risk factors. It will be assumed that the causal
effect of risk factor 1 on the outcome is of primary interest and all the genetic variants
are uncorrelated.
Inverse-variance weighted estimate:
The inverse-variance weighted (IVW) estimate using summary statistics (equation 2)
can be calculated by:
thetaUI = sum(bY*bX1*bYse^-2)/sum(bX1^2*bYse^-2)
se_thetaUI = 1/sqrt(sum(bX1^2*bYse^-2))
The same IVW estimate using summary statistics can be obtained using weighted
linear regression (equation 3):
thetaUI = summary(lm(bY~bX1-1, weights=bYse^-2))$coef[1]
se_thetaUI.fixed = summary(lm(bY~bX1-1, weights=bYse^-2))$coef[1,2]/
summary(lm(bY~bX1-1, weights=bYse^-2))$sigma
se_thetaUI.random = summary(lm(bY~bX1-1, weights=bYse^-2))$coef[1,2]/
min(summary(lm(bY~bX1-1, weights=bYse^-2))$sigma,1)
In the fixed-effect model we divide the standard error of the causal estimate by
the estimated residual standard error to force the residual standard error to be 1.
For the multiplicative random-effect model the standard error is divided by the esti-
mated residual standard error when the variability in the genetic associations is less
than expected by chance (underdispersion). When there is evidence of heterogeneity
between the causal estimates (overdispersion) the standard error is unaltered. The
multiplicative random-effects model will result in a larger standard error compared
to the fixed-effect model if there is heterogeneity between the causal estimates. The
causal estimate obtained from the fixed- and multiplicative random-effects models will
be the same.
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Univariable MR-Egger:
The univariable MR-Egger method is the same as the IVW method using weighted
linear regression except the intercept term is estimated rather than being set to zero.
Testing whether the intercept term is equal to zero is equivalent to testing for direc-
tional pleiotropy and the validity of the InSIDE assumption. The genetic associations
with the risk factor bX1 and outcome bY must be orientated with respect to the risk
increasing or decreasing allele of the risk factor. Under the MR-Egger model, mul-
tiplicative random-effects should be used as the presence of pleiotropy will lead to
overdispersion. Since the residual standard error is estimated, we use the t-distribution
with J − 2 degrees of freedom for inference.
#Orientation of the genetic associations
bY<-ifelse(bX1>0, bY, bY*-1)
bX1<-abs(bX1)
#Causal estimate
thetaUE = summary(lm(bY~bX1, weights=bYse^-2))$coef[2]
se_thetaUE.random = summary(lm(bY~bX1, weights=bYse^-2))$coef[2,2]/
min(summary(lm(bY~bX1, weights=bYse^-2))$sigma,1)
lb_thetaUE = thetaUE - qt(0.975,df=length(bX1)-2)*se_thetaUE.random
ub_thetaUE = thetaUE + qt(0.975,df=length(bX1)-2)*se_thetaUE.random
p_thetaUE = 2*(1-pt(abs(thetaUE/se_thetaUE.random),df=length(bX1)-2))
#Test for directional pleiotropy
interUE = summary(lm(bY~bX1, weights=bYse^-2))$coef[1]
se_interUE.random = summary(lm(bY~bX1, weights=bYse^-2))$coef[1,2]/
min(summary(lm(bY~bX1, weights=bYse^-2))$sigma,1)
p_interUE = 2*(1-pt(abs(interUE/se_interUE.random),df=length(bX1)-2))
Multivariable IVW:
The multivariable IVW method expands the IVW method using weighted linear re-
gression by estimating the causal effects of the additional risk factors on the outcome.
We will include additional two risk factors and assume the causal estimate of interest is
the effect of risk factor 1 on the outcome. Either fixed- or multiplicative random-effects
can be used to estimate the standard error of the causal effect.
theta1MI = summary(lm(bY~bX1+bX2+bX3-1, weights=bYse^-2))$coef[1]
se_theta1MI.fixed = summary(lm(bY~bX1+bX2+bX3-1, weights=bYse^-2))$coef[1,2]/
summary(lm(bY~bX1+bX2+bX3-1, weights=bYse^-2))$sigma
se_theta1MI.random = summary(lm(bY~bX1+bX2+bX3-1, weights=bYse^-2))$coef[1,2]/
min(summary(lm(bY~bX1+bX2+bX3-1, weights=bYse^-2))$sigma,1)
Multivariable MR-Egger:
The multivariable MR-Egger method is equivalent to the multivariable IVW method
using weighted linear regression except the intercept is estimated rather than being
set to zero. Testing whether the intercept term is equal to zero is equivalent to testing
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for directional pleiotropy and the validity of the InSIDE assumption. As with uni-
variable MR-Egger, the standard errors should be calculated from the multiplicative
random-effects model. The genetic associations should be orientated with respect to
the risk increasing or decreasing allele of the risk factor of interest. In this sample
code we will assume the causal effect of risk factor 1 is of primary interest. Since the
residual standard error is estimated for the multivariable MR-Egger model we use the
t-distribution with J − (K + 1) degrees of freedom for inference.
#Orientation of the genetic associations with respect to X1
clist<-c("bX2","bX3","bY")
for (var in clist){
eval(parse(text=paste0(var,"<-ifelse(bX1>0,",var,",",var,"*-1)")))
}
bX1<-abs(bX1)
#Causal estimate for X1
theta1ME = summary(lm(bY~bX1+bX2+bX3, weights=bYse^-2))$coef[2]
se_theta1ME.random = summary(lm(bY~bX1+bX2+bX3, weights=bYse^-2))$coef[2,2]/
min(summary(lm(bY~bX1+bX2+bX3, weights=bYse^-2))$sigma,1)
lb_theta1ME = theta1ME - qt(0.975,df=length(bX1)-4)*se_theta1ME.random
ub_theta1ME = theta1ME + qt(0.975,df=length(bX1)-4)*se_theta1ME.random
p_theta1ME = 2*(1-pt(abs(theta1ME/se_theta1ME.random),df=length(bX1)-4))
#Test for directional pleiotropy
interME = summary(lm(bY~bX1+bX2+bX3, weights=bYse^-2))$coef[1]
se_interME.random = summary(lm(bY~bX1+bX2+bX3, weights=bYse^-2))$coef[1,2]/
min(summary(lm(bY~bX1+bX2+bX3, weights=bYse^-2))$sigma,1)
p_interME = 2*(1-pt(abs(interME/se_interME.random),df=length(bX1)-4))
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A2 Comparison between the precision of the causal
estimates from univariable and multivariable
MR-Egger
In this section, we compare the precision of the causal estimates from the univariable
(θˆ1UE) and multivariable (θˆ1ME) MR-Egger models. For the multivariable model, we
consider the genetic associations βXk with two risk factors (k = 2), where the variance
of the multivariable MR-Egger estimate θˆ1ME is given by:
var(θˆ1ME) =
φ2 var(βX2)
N(var(βX1) var(βX2)− cov(βX1,βX2)
2)
∝ [var(βX1)(1− cor(βX1 ,βX2)
2)]−1 (1)
Under a fixed-effect model, the variance of the univariable MR-Egger estimate is
proportional to the inverse of var(βX1) [1]. The estimate from the multivariable MR-
Egger model θˆ1ME will be more precise than its univariable counterpart θˆ1UE if:
1
var(βX1)
>
1
var(βX1)(1− cor(βX1 ,βX2)2)
(2)
From the above inequality, θˆ1UE will always be more precise than θˆ1ME when βX1 and
βX2 are correlated. Under a multiplicative random-effects model (used throughout this
paper), the variance of the residual error is estimated under the univariable MR-Egger
model (φ2UE) and the multivariable MR-Egger model (φ
2
ME). For θˆ1ME to be more
precise than θˆ1UE , we require:
φ2UE
var(βX1)
>
φ2ME
var(βX1)(1− cor(βX1 ,βX2)2)
(3)
If βX2 explains additional independent variability in the genetic associations with the
outcome βY , and βX1 and βX2 are independent, then the estimate from multivariable
MR-Egger will be more precise than the estimate from univariable MR-Egger. If βX1
and βX2 are correlated, then the precision of θˆ1ME will depend upon the strength
of the correlation between βX1 and βX2 , and the amount of additional independent
variability βX2 explains in βY . As the correlation between βX1 and βX2 increases,
and βX2 explains no additional independent variability in βY , the precision of the
multivariable MR-Egger estimate θˆ1ME will decrease.
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A3 Summary statistics for the data used in the ap-
plied example
Applied MR studies usually report the proportion of variance in the exposure explained
by the genetic variants (R2) and a measurement of the strength of the instrumental
variables (F-statistic). Instrumental variables are often considered to be strong if
they have a F-statistic greater than 10 [2]. Since the simulation study generated
the summarized data directly, it was not possible to estimate the R2 and F-statistic
without making additional assumptions. We therefore provide estimates of the R2 and
F-statistic from the applied example. The F-statistic was calculated using the formula:
F-statisic =
(
N − k − 1
k
)(
R2
1− R2
)
(4)
where N is the number of participants (188,578) and k is the number of genetic variants
(185). For LDL-C, the estimated value for R2 was 8.7% and the F-statistic was 96.7.
For HDL-C, R2 was 9.6% and the F-statistic was 107.9, whilst triglycerides had a R2
value of 5.9% and F-statistic of 64.1. In this example, the F-statistics are large due to
the large sample size and the high R2 values.
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A4 Details and results from the simulation study
investigating causal relationships between risk
factors
To investigate the behaviour of the multivariable MR-Egger method when causal rela-
tionships between risk factors exist, additional simulations were performed where X2
was causally dependent on X1. We assume that X2 is causally dependent on X1, and
the causal effect of X1 on X2 is γ. The total causal effect of X1 on Y is θ1 + γθ2;
consisting of the direct effect (θ1) and the indirect effect via X2 (γθ2). The simulations
outlined in Section 4 were repeated with the second line in the data generating model
replaced with:
βYj = α
′
j + θ1|βX1j |+ θ2(βX2j + γ|βX1j |) + θ3βX3j + ǫj (5)
The causal effect of X1 on X2 (γ) was set to 0.5. All other parameters were taken as
in the original simulation study. |βX1j |, (βX2j + γ|βX1j |), and βX3j were the covariates
included in the multivariable IVW and multivariable MR-Egger models. Note that the
functional relationship between X1 and X2 induces a correlation structure between the
covariates |βX1j | and (βX2j + γ|βX1j |) included in the multivariable models, even when
βX1 and βX2 are generated independently. To account for the additional uncertainty in
βYj , the weights for univariable MR-Egger are given by equation 6, while the weights
for multivariable IVW and multivariable MR-Egger were the same as the original
simulation study (equation 15).
se(βYj)
−2 = (ǫj
2 + σα′
2 + θ2
2σ2
2 + (θ2γ)
2σ1
2 + 2θ2γρ12σ1σ2 + θ3
2σ3
2)
−1
(6)
Results
The results from the simulations that included a causal relationship between X1 and
X2, using 10 000 simulated datasets, are presented in Web Table A1 (βXk generated
independently, with the functional relationship between X1 and X2 inducing a correla-
tion structure between |βX1j | and (βX2j+γ|βX1j |)) and Web Table A2 (βXk correlated).
βXk generated independently, with a correlation structure between the
covariates |βX1j | and (βX2j + γ|βX1j |): In scenarios where there was no bias in the
original set of simulations, the multivariable IVW and multivariable MR-Egger meth-
ods consistently estimated the direct effect of X1 on Y (θ1), whilst the univariable
MR-Egger method consistently estimated the total causal effect of X1 on Y (θ1+γθ2).
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Bias for the multivariable IVW method was present in scenarios 3 and 4 only, as in
the original simulation study (Tables 3 and 4). Compared to the results in Table 3,
precision and power to detect a causal effect were reduced for the multivariable IVW
and multivariable MR-Egger methods. This reduction in power may be due to the
correlation structure between |βX1j | and (βX2j +γ|βX1j |), and the multivariable models
conditioning on a mediator. Univariable and multivariable MR-Egger methods pro-
duced biased estimates of the total and direct causal effects in scenario 4 (InSIDE
violated) only. Unlike the original simulation study, precision and power to detect a
causal effect were always better for the univariable MR-Egger method.
βXk correlated: The multivariable IVW and multivariable MR-Egger methods
estimated the direct effect of X1 on Y , as in the independently generated setting. As
with the original simulations (Tables 3 and 4), the InSIDE assumption for univariable
MR-Egger was violated for all four scenarios, resulting in biased point estimates. How-
ever, as with the original simulation study, the multivariable InSIDE assumption was
satisfied for scenarios 1,2 and 3, and so causal estimates from multivariable MR-Egger
were unbiased. There was a more noticeable reduction in the precision and power to
detect a causal effect for the multivariable IVW and multivariable MR-Egger methods
under the correlated setting.
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Table A1: Performance of multivariable IVW, univariable MR-Egger and multivariable MR-Egger
with respect to θˆ1 for a null (θ1 = 0) and positive (θ1 = 0.3) causal effect where βXk are generated
independently for all k (with a correlation structure between the covariates |βX1j | and (βX2j+γ|βX1j |)),
with a causal effect of X1 on X2 (γ = 0.5). All tests were performed at the 5% level of significance.
Multivariable IVW Univariable MR-Egger Multivariable MR-Egger
Mean θˆ1 Power, Mean θˆ1 Power, % Mean θˆ1 Power, %
(mean SE) % (mean SE) Intercept Causal (mean SE) Intercept Causal
Null causal effect: θ1 = 0
1. No pleiotropy, InSIDE satisfied
0.000 (0.057) 3.5 0.051 (0.158) 8.9 5.8 0.001 (0.090) 4.5 4.2
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) 0.001 (0.127) 4.4 0.049 (0.187) 7.6 5.6 0.001 (0.178) 4.6 4.2
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.041 (0.127) 6.0 0.049 (0.187) 12.3 5.4 0.000 (0.178) 5.8 4.8
α′j ∼ N (0.05,0.004) 0.195 (0.128) 34.4 0.048 (0.187) 50.1 5.3 -0.001 (0.178) 36.6 4.6
α′j ∼ N (0.1,0.004) 0.393 (0.130) 82.3 0.052 (0.187) 91.4 5.6 0.002 (0.178) 88.4 4.7
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.076 (0.127) 9.8 0.138 (0.187) 6.4 11.6 0.088 (0.178) 4.3 7.6
α′j ∼ N (0.05,0.004) 0.231 (0.127) 45.2 0.137 (0.187) 34.4 11.9 0.088 (0.178) 21.7 8.2
α′j ∼ N (0.1,0.004) 0.426 (0.129) 88.3 0.141 (0.187) 83.7 11.9 0.089 (0.178) 78.2 8.1
Positive causal effect: θ1 = 0.3
1. No pleiotropy, InSIDE satisfied
0.301 (0.057) 96.3 0.353 (0.158) 9.3 62.3 0.301 (0.090) 3.9 84.6
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) 0.298 (0.127) 65.4 0.350 (0.187) 7.4 47.8 0.298 (0.178) 4.4 41.2
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.338 (0.127) 75.5 0.352 (0.187) 11.8 48.3 0.300 (0.178) 6.1 41.1
α′j ∼ N (0.05,0.004) 0.494 (0.128) 95.2 0.348 (0.188) 49.2 46.9 0.298 (0.179) 36.8 40.3
α′j ∼ N (0.1,0.004) 0.689 (0.130) 99.6 0.347 (0.188) 91.5 47.1 0.296 (0.178) 88.2 39.6
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.375 (0.127) 82.6 0.440 (0.187) 6.6 65.7 0.390 (0.178) 4.7 60.1
α′j ∼ N (0.05,0.004) 0.530 (0.128) 97.0 0.438 (0.187) 34.7 65.5 0.386 (0.178) 21.7 59.9
α′j ∼ N (0.1,0.004) 0.728 (0.129) 99.7 0.441 (0.187) 83.6 65.8 0.390 (0.178) 78.5 60.1
Abbreviations: MR, Mendelian randomization; SE, standard error; IVW, inverse-variance weighted;
InSIDE, Instrument Strength Independent of Direct Effect.
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Table A2: Performance of multivariable IVW, univariable MR-Egger and multivariable MR-Egger
with βXk being correlated for all k, and a causal effect of X1 on X2
Multivariable IVW Univariable MR-Egger Multivariable MR-Egger
Mean θˆ1 Power, Mean θˆ1 Power, % Mean θˆ1 Power, %
(mean SE) % (mean SE) Intercept Causal (mean SE) Intercept Causal
Null causal effect: θ1 = 0
1. No pleiotropy, InSIDE satisfied
0.000 (0.062) 4.1 0.146 (0.158) 3.9 15.6 0.000 (0.097) 4.0 4.0
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) 0.000 (0.137) 4.5 0.146 (0.188) 4.1 11.9 0.000 (0.190) 4.6 4.7
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.041 (0.137) 5.7 0.151 (0.187) 5.4 12.8 0.003 (0.189) 5.7 4.4
α′j ∼ N (0.05,0.004) 0.209 (0.138) 34.2 0.148 (0.187) 32.8 12.6 0.000 (0.190) 36.9 4.7
α′j ∼ N (0.1,0.004) 0.422 (0.140) 82.2 0.151 (0.188) 83.0 12.9 0.004 (0.190) 89.0 4.8
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.053 (0.137) 6.2 0.235 (0.188) 4.3 25.7 0.069 (0.189) 4.9 6.4
α′j ∼ N (0.05,0.004) 0.218 (0.137) 37.2 0.235 (0.188) 20.3 26.4 0.067 (0.189) 21.8 6.7
α′j ∼ N (0.1,0.004) 0.429 (0.139) 84.3 0.238 (0.188) 71.3 26.7 0.071 (0.189) 79.2 6.6
Positive causal effect: θ1 = 0.3
1. No pleiotropy, InSIDE satisfied
0.299 (0.062) 94.7 0.446 (0.158) 4.1 79.7 0.300 (0.096) 4.0 81.3
2. Balanced pleiotropy, InSIDE satisfied
α′j ∼ N (0,0.004) 0.301 (0.137) 60.5 0.445 (0.187) 4.5 66.6 0.300 (0.189) 4.6 37.0
3. Directional pleiotropy, InSIDE satisfied
α′j ∼ N (0.01,0.004) 0.339 (0.137) 69.9 0.443 (0.188) 5.7 66.1 0.296 (0.190) 6.0 36.1
α′j ∼ N (0.05,0.004) 0.510 (0.138) 94.2 0.449 (0.188) 32.6 67.7 0.302 (0.190) 37.3 37.2
α′j ∼ N (0.1,0.004) 0.715 (0.140) 99.2 0.445 (0.187) 83.4 66.9 0.298 (0.189) 89.4 36.8
4. Directional pleiotropy, InSIDE violated
α′j ∼ N (0.01,0.004) 0.353 (0.137) 73.1 0.534 (0.188) 4.4 79.4 0.367 (0.189) 4.6 50.6
α′j ∼ N (0.05,0.004) 0.519 (0.138) 95.1 0.534 (0.188) 20.3 79.6 0.366 (0.190) 21.7 50.5
α′j ∼ N (0.1,0.004) 0.728 (0.139) 99.5 0.533 (0.188) 72.5 79.6 0.368 (0.189) 80.1 51.0
Abbreviations: MR, Mendelian randomization; SE, standard error; IVW, inverse-variance weighted;
InSIDE, Instrument Strength Independent of Direct Effect.
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A5 Correlated genetic variants
The methods discussed in this article have assumed that the genetic variants are un-
correlated (not in linkage disequilibrium). There may, however, be cases where using
multiple correlated variants from the same gene region will be more efficient than using
uncorrelated variants from different gene regions [3]. If the genetic variants are in par-
tial linkage disequilibrium, and each variant explains independent variation in the risk
factor, then the inclusion of these variants will increase the power of the MR study.
The precision of a MR study will not increase, however, if the variants are perfectly
correlated.
If correlated variants are included in an MR study, using summarized level data, the
analysis should account for the correlation structure of the variants. If the correlation
of the variants is not taken into consideration, the causal estimate will be too precise
and this may lead to inappropriate inferences. To account for the correlation between
the genetic variants for the univariable and multivariable IVW methods, we can use
generalized weighted linear regression of the genetic associations, where the correlations
of the variants are included in the weighting matrix, with the intercept set to zero [4, 3].
If Ωst = se(βˆYs) se(βˆYt)ρst, where ρst is the correlation between variants s and t,
then the causal estimate from a weighted generalised linear regression for univariable
MR is:
θˆUIC = (βˆ
T
Xj
Ω−1βˆXj )
−1βˆTXjΩ
−1βˆYj (7)
with the standard error of the causal estimate:
θˆUIC =
√
(βˆTXjΩ
−1βˆXj)
−1 (8)
Whilst the univariable MR-Egger estimates can be obtained by fitting the same general-
ized weighted linear regression model, but allowing the intercept term to be estimated,
the effect of using correlated genetic variants in the univariable MR-Egger method has
not been considered in detail. Further investigation into the impact correlated vari-
ants may have on the interpretation of the direct effect, and the InSIDE assumption,
must be considered at the univariable level first, and then expanded to multivariable
MR-Egger.
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